We are live on
!
Find out more
PCM
Poehling Capital Management Portfolio holdings
AUM
$466M
1-Year Est. Return
24.17%
This Fund
S&P 500
This Quarter
Est. Return
-15.77%
1 Year Est. Return
+24.17%
3 Year Est. Return
+70.93%
5 Year Est. Return
+69.6%
10 Year Est. Return
–
AUM
$104M
AUM Growth
-$37.4M
(-27%)
Cap. Flow
-$14.1M
Cap. Flow
% of AUM
-13.59%
Top 10 Holdings %
Top 10 Hldgs %
39.92%
Holding
108
New
3
Increased
20
Reduced
64
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Markel Group
MKL
|
+$2.12M |
| 2 |
Labcorp
LH
|
+$1.72M |
| 3 |
Bank OZK
OZK
|
+$1.63M |
| 4 |
Philip Morris
PM
|
+$1.19M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
B&G Foods
BGS
|
+$2.07M |
| 2 |
Synchrony
SYF
|
+$1.84M |
| 3 |
Johnson & Johnson
JNJ
|
+$1.44M |
| 4 |
AutoNation
AN
|
+$1.25M |
| 5 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$1.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 39.34% |
| 2 | Healthcare | 14.12% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 8.02% |
| 5 | Technology | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class B
BRK.B
$1.07T
| $10.9M | 10.49% |
53,272
-935
| -2% | -$195K |
|
|
WBA
2
DELISTED
Walgreens Boots Alliance
WBA
| $5.24M | 5.05% |
76,627
-6,719
| -8% | -$521K |
|
3
Microsoft
MSFT
$2.84T
| $4.39M | 4.24% |
43,249
-4,450
| -9% | -$477K |
|
4
Cannae Holdings
CNNE
$647M
| $3.99M | 3.85% |
233,250
-39,825
| -15% | -$717K |
|
|
FDC
5
DELISTED
First Data Corporation
FDC
| $3.35M | 3.23% |
198,340
-4,230
| -2% | -$82.5K |
|
|
FFH
6
DELISTED
FAIRFAX FINL HLDGS LTD SUB VTG
FFH
| $3.28M | 3.16% |
7,438
+392
| +6% | +$173K |
|
7
Visa
V
$677B
| $3.09M | 2.98% |
23,428
-565
| -2% | -$78K |
|
8
PepsiCo
PEP
$186B
| $2.45M | 2.36% |
22,137
-1,100
| -5% | -$124K |
|
|
9
Markel Group
MKL
$25B
| $2.43M | 2.34% |
2,337
+1,938
| +486% | +$2.12M |
|
10
Park Hotels & Resorts
PK
$2.97B
| $2.3M | 2.22% |
88,672
-4,224
| -5% | -$125K |
|
11
Citigroup
C
$222B
| $2.25M | 2.17% |
43,157
-4,590
| -10% | -$291K |
|
12
CVS Health
CVS
$137B
| $2.22M | 2.14% |
33,944
-502
| -1% | -$37.5K |
|
13
Gilead Sciences
GILD
$161B
| $1.94M | 1.87% |
30,982
-8,160
| -21% | -$570K |
|
|
BNY
14
Bank of New York Mellon
BNY
$108B
| $1.77M | 1.71% |
37,591
-1,085
| -3% | -$52.7K |
|
15
Bank of America
BAC
$435B
| $1.76M | 1.7% |
71,527
-2,390
| -3% | -$64.8K |
|
16
PayPal
PYPL
$49.5B
| $1.7M | 1.64% |
20,198
-1,140
| -5% | -$94.9K |
|
17
Target
TGT
$62.1B
| $1.67M | 1.61% |
25,261
-875
| -3% | -$67.3K |
|
18
Marathon Petroleum
MPC
$90.3B
| $1.62M | 1.56% |
27,484
+9,799
| +55% | +$669K |
|
|
19
Philip Morris
PM
$301B
| $1.42M | 1.36% |
21,194
+14,230
| +204% | +$1.19M |
|
20
First Business Financial Services
FBIZ
$562M
| $1.41M | 1.36% |
72,327
-1,000
| -1% | -$20.7K |
|
21
Atlanta Braves Holdings Series B
BATRK
$3.23B
| $1.4M | 1.35% |
56,146
-2,380
| -4% | -$60.2K |
|
|
22
Labcorp
LH
$24.3B
| $1.4M | 1.35% |
+12,865
| New | +$1.72M |
|
|
23
Bank OZK
OZK
$5.49B
| $1.34M | 1.29% |
+58,610
| New | +$1.63M |
|
24
AbbVie
ABBV
$458B
| $1.26M | 1.21% |
13,656
+5,391
| +65% | +$474K |
|
|
25
Alphabet (Google) Class C
GOOG
$3.9T
| $1.25M | 1.21% |
24,220
+20,660
| +580% | +$1.11M |
|
Similar funds
UC
JHC
HP
LS
ACGA
PC
VCM
SP
Poehling Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Poehling Capital Management held 108 positions worth $104M, down 27% from $141M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Poehling Capital Management withdrew a net $14.1M in Q4 2018, closing 15 positions and reducing 64 holdings. Its most notable exit was B&G Foods, an estimated $2.07M position sold in full.
By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Poehling Capital Management opened a new position in Labcorp worth $1.4M.
- Poehling Capital Management's largest Q4 2018 buy was Labcorp: 12,865 shares worth $1.4M.
- Poehling Capital Management added most to Markel Group in Q4 2018, an estimated $2.12M increase.
- Poehling Capital Management's biggest Q4 2018 reduction was Johnson & Johnson, cutting an estimated $1.44M.
- Poehling Capital Management fully exited B&G Foods in Q4 2018, selling an estimated $2.07M.
- Poehling Capital Management's ten largest holdings make up 40% of its $104M portfolio in Q4 2018.
- Poehling Capital Management opened 3 new positions and closed 15 in Q4 2018.
- Poehling Capital Management's portfolio value fell 27% quarter-over-quarter to $104M.
Based on Poehling Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.